health care

  • U.S. Insurers Wasted Millions on Ivermectin for COVID-19, Study Finds

    U.S. Insurers Wasted Millions on Ivermectin for COVID-19, Study Finds

    Researchers analysing insurance claims data estimate that U.S. insurers have paid tens of millions of dollars for ivermectin as a COVID-19 treatment, despite little good evidence that ivermectin does anything to treat or prevent the viral illness. During a single week in August 2021, private and Medicare insurance plans forked over about $US2.5 (A$3) million…